51st week of 2018 patent applcation highlights part 11 |
Patent application number | Title | Published |
20180360905 | INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES | 2018-12-20 |
20180360906 | METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION | 2018-12-20 |
20180360907 | ANTI-INFLAMMATORY PEPTIDES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) | 2018-12-20 |
20180360908 | OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE | 2018-12-20 |
20180360909 | FORMULATIONS COMPRISING CYCLOSPORIN A | 2018-12-20 |
20180360910 | MITOCHONDRIAL-DERIVED PEPTIDE MOTS3 REGULATES METABOLISM AND CELL SURVIVAL | 2018-12-20 |
20180360911 | ATHEROSCLEROSIS INHIBITION VIA MODULATION OF MONOCYTE-MACROPHAGE PHENOTYPE USING APO A-I MILANO GENE TRANSFER | 2018-12-20 |
20180360912 | TREATMENT OF EYE DISEASE | 2018-12-20 |
20180360913 | COMPOSITIONS AND METHODS FOR MODULATING STEM CELLS AND USES THEREOF | 2018-12-20 |
20180360914 | Compositions and Methods for Treating Rotator Cuff Injuries | 2018-12-20 |
20180360915 | Compositions and Methods for Treating Rotator Cuff Injuries | 2018-12-20 |
20180360916 | Isolation and Identification of Glycosaminoglycans | 2018-12-20 |
20180360917 | SINCALIDE FORMULATIONS AND METHODS OF USE | 2018-12-20 |
20180360918 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL) AMINO) CAPRYLIC ACID | 2018-12-20 |
20180360919 | METHODS OF INDUCING MELANOGENESIS IN A SUBJECT | 2018-12-20 |
20180360920 | SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT | 2018-12-20 |
20180360921 | Materials and Methods for Treatment of Titin-Based Myopathies and other Titinopathies | 2018-12-20 |
20180360922 | MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF | 2018-12-20 |
20180360923 | Oncological and Neurological Therapy based on ATM, CHK2 and p53 proteins for DNA correction of transcription errors | 2018-12-20 |
20180360924 | TELOMERE EXTENSION AND ANTI-INFLAMMATORY AGENTS FOR CELL REGENERATION | 2018-12-20 |
20180360925 | EXTRACELLULAR DNA AS A THERAPEUTIC TARGET IN NEURODEGENERATION | 2018-12-20 |
20180360926 | ANIMAL FEED COMPOSITIONS AND METHODS OF USE | 2018-12-20 |
20180360927 | ENZYMATIC REPLACEMENT THERAPY AND ANTISENSE THERAPY FOR POMPE DISEASE | 2018-12-20 |
20180360928 | HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE | 2018-12-20 |
20180360929 | ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCLEOSIDE HYDROLASE PRODRUG | 2018-12-20 |
20180360930 | METHOD FOR PREVENTING OR TREATING DIABETIC RETINOPATHY | 2018-12-20 |
20180360931 | DRUG TARGET FOR PREVENTING AND TREATING PERIODONTAL DISEASE, IMPROVING HEALING OF PERIODONTAL WOUNDS AND PROMOTING ORAL HEALTH | 2018-12-20 |
20180360932 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | 2018-12-20 |
20180360933 | Inotropic Antibodies And Therapeutic Uses Thereof | 2018-12-20 |
20180360934 | TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS | 2018-12-20 |
20180360935 | COMPOSITIONS AND METHODS RELATED TO xCT PEPTIDES | 2018-12-20 |
20180360936 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | 2018-12-20 |
20180360937 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | 2018-12-20 |
20180360938 | UBE2T PEPTIDES AND VACCINES CONTAINING THE SAME | 2018-12-20 |
20180360939 | DRIED COMPOSITION | 2018-12-20 |
20180360940 | LISTERIA-BASED IMMUNOTHERAPY AND METHODS OF USE THEREOF | 2018-12-20 |
20180360941 | HELICOBACTER PYLORI VACCINES | 2018-12-20 |
20180360942 | ATTENUATED VACCINES TO PROTECT AGAINST TICK-BORNE EHRLICHIA SPECIES INFECTIONS | 2018-12-20 |
20180360943 | LIPIDATED STREPTOCOCCUS PNEUMONIAE ANTIGEN COMPOSITIONS, METHODS OF PREPARATION AND USE | 2018-12-20 |
20180360944 | A NOVEL PROCESS FOR PRODUCTION OF PURIFIED RECOMBINANT CHOLERA TOXIN B (rCTB) AND FORMU LATION THEREON | 2018-12-20 |
20180360945 | INACTIVATION OF VIRUSES BY DELIPIDATION | 2018-12-20 |
20180360946 | DENGUE VIRUS GLYCOPROTEIN E DIII VARIANTS AND USES THEREOF | 2018-12-20 |
20180360947 | COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS | 2018-12-20 |
20180360948 | ANTIBODY EVOLUTION IMMUNOGENS | 2018-12-20 |
20180360949 | IMMUNOGENIC COMPOSITIONS | 2018-12-20 |
20180360950 | IMMUNOGENIC CONSTRUCT COMPRISING AN EBV-CELL ANTIGEN AND A TARGETING MOIETY AND APPLICATIONS THEREOF | 2018-12-20 |
20180360951 | METHOD, COMPOSITION & APPARATUS FOR THE TREATMENT OF TYPE I ALLERGIC HYPERSENSITIVITIES BY IMMUNE DESENSITIZATION THROUGH SLIT IMMUNOTHERAPY WITH UNADULTERATED ALLERGEN, VITAMIN A AND VITAMIN D | 2018-12-20 |
20180360952 | LIPID VESICLE COMPOSITIONS AND METHODS OF USE | 2018-12-20 |
20180360953 | METHODS TO IMPROVE INDUCTION OF IGG AND IGA ANTIBODIES BY VACCINES | 2018-12-20 |
20180360954 | BRANCHED AND LINEAR CHIMERIC COMPOUNDS, POLYNUCLEOTIDES, USES AND METHODS FOR PREPARATION THEREOF | 2018-12-20 |
20180360955 | VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES | 2018-12-20 |
20180360956 | Vaccine | 2018-12-20 |
20180360957 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | 2018-12-20 |
20180360958 | VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT | 2018-12-20 |
20180360959 | AGENTS INHIBITING KALLIKREIN-8 FOR USE IN THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE | 2018-12-20 |
20180360960 | TREATMENT OF PSYCHIATRIC CONDITIONS | 2018-12-20 |
20180360961 | MESSENGER RNA THERAPY FOR TREATMENT OF ARTICULAR DISEASE | 2018-12-20 |
20180360962 | COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE | 2018-12-20 |
20180360963 | NEUTRON CAPTURE THERAPY SYSTEM FOR ELIMINATING AMYLOID -PROTEIN | 2018-12-20 |
20180360964 | PHARMACEUTICAL COMPOSITION AND A METHOD FOR PRODUCING THEREOF | 2018-12-20 |
20180360965 | STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF | 2018-12-20 |
20180360966 | INJECTABLE PHARMACEUTICAL FORMULATIONS OF LEFAMULIN | 2018-12-20 |
20180360967 | Orally Dissolving Melatonin Formulation With Acidifying Agent That Renders Melatonin Soluble In Saliva | 2018-12-20 |
20180360968 | PATCH | 2018-12-20 |
20180360969 | IMMUNOGLOBULIN PREPARATION | 2018-12-20 |
20180360970 | BIOMATERIALS FOR DELIVERY OF BLOOD EXTRACTS AND METHODS OF USING SAME | 2018-12-20 |
20180360971 | PAZOPANIB FORMULATION | 2018-12-20 |
20180360972 | THERAPEUTIC COMPOUNDS | 2018-12-20 |
20180360973 | PROTEIN CONJUGATE USING A FATTY ACID DERIVATIVE AND METHOD FOR PREPARATION THEREOF | 2018-12-20 |
20180360974 | RELEASABLE CONJUGATES | 2018-12-20 |
20180360975 | COMPOSITIONS AND METHODS FOR INCREASING EFFICIENCY OF CARDIAC METABOLISM | 2018-12-20 |
20180360976 | Complex Coacervate for Controlled Release and Related Methods | 2018-12-20 |
20180360977 | Interleukin-15 Compositions and Uses Thereof | 2018-12-20 |
20180360978 | POLYACETAL POLYMERS, CONJUGATES, PARTICLES AND USES THEREOF | 2018-12-20 |
20180360979 | BIOORTHOGONAL COMPOSITIONS | 2018-12-20 |
20180360980 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | 2018-12-20 |
20180360981 | NOVEL IMMUNOGLOBULIN VARIANTS | 2018-12-20 |
20180360982 | FACTOR VIII CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF | 2018-12-20 |
20180360983 | POLYPEPTIDE COMPLEX COMPRISING NON-PEPTIDYL POLYMER HAVING THREE FUNCTIONAL ENDS | 2018-12-20 |
20180360984 | Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation | 2018-12-20 |
20180360985 | CD38 Antibody Drug Conjugate | 2018-12-20 |
20180360986 | ANTIBODY-DRUG CONJUGATE HAVING IMPROVED STABILITY AND USE THEREOF | 2018-12-20 |
20180360987 | THERAPEUTIC NANOFIBER HYDROGELS FOR LOCAL TREATMENT OF BRAIN-RELATED DISEASES | 2018-12-20 |
20180360988 | MICELLES AND METHODS | 2018-12-20 |
20180360989 | In Vivo Radical-Mediated Polymerization for Targeted Delivery of Trophic Factors | 2018-12-20 |
20180360990 | NANOSYSTEMS FOR CONTROLLED TRANSPORT OF ACTIVE MOLECULES FOR DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC PURPOSES | 2018-12-20 |
20180360991 | HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE POLYPEPTIDE | 2018-12-20 |
20180360992 | COMPOSITIONS AND METHODS FOR EXPRESSION OF MULTIPLE BIOLOGICALLY ACTIVE POLYPEPTIDES FROM A SINGLE VECTOR FOR TREATMENT OF CARDIAC CONDITIONS AND OTHER PATHOLOGIES | 2018-12-20 |
20180360993 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING NEUROINFLAMMATION, NEURODEGENERATION, NEUROPATHIC PAIN, AND MIGRAINE | 2018-12-20 |
20180360994 | System, device and a method for providing a therapy or a cure for cancer and other pathological states | 2018-12-20 |
20180360995 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES | 2018-12-20 |
20180360996 | ANTI-TUMOR COMPOSITION COMPRISING GM-CSF GENE, Flt3L-TRAIL FUSION GENE, shRNA INHIBITING TGF-BETA EXPRESSION, AND shRNA INHIBITING HSP EXPRESSION | 2018-12-20 |
20180360997 | Method of using methylene blue nanoparticle for detecting cancer by bioimaging | 2018-12-20 |
20180360998 | Fluorescent Fluid for Detecting Fluid Injection | 2018-12-20 |
20180360999 | HYPERPOLARIZED NOBLE GAS PRODUCTION SYSTEMS WITH NANOCLUSTER SUPPRESSION, DETECTION AND/OR FILTERING AND RELATED METHODS AND DEVICES | 2018-12-20 |
20180361000 | DEXTRAN NANOPARTICLES FOR MACROPHAGE SPECIFIC IMAGING AND THERAPY | 2018-12-20 |
20180361001 | BABY FEEDING PRODUCT STERILIZATION DEVICE AND METHODS | 2018-12-20 |
20180361002 | Sanitizing Assembly | 2018-12-20 |
20180361003 | DISINFECTANT CAPS | 2018-12-20 |
20180361004 | INDANE DERIVATIVES FOR MALODOR COUNTERACTION | 2018-12-20 |